Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to β-agonist therapy
- 30 November 1991
- journal article
- clinical trial
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 20 (11) , 1206-1209
- https://doi.org/10.1016/s0196-0644(05)81472-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- NEBULISED SALBUTAMOL WITH AND WITHOUT IPRATROPIUM BROMIDE IN ACUTE AIRFLOW OBSTRUCTIONThe Lancet, 1989
- Ipratropium BromideNew England Journal of Medicine, 1988
- Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency roomThe American Journal of Medicine, 1987
- Cholinergic and neurogenic mechanisms in obstructive airways diseaseThe American Journal of Medicine, 1986
- Ipratropium bromide in chronic bronchitis/emphysema: A review of the literatureThe American Journal of Medicine, 1986
- Ipratropium bromide in asthma: A review of the literatureThe American Journal of Medicine, 1986
- Clinical pharmacology and toxicology of ipratropium bromideThe American Journal of Medicine, 1986
- Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamolRespiratory Medicine, 1980
- Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitisRespiratory Medicine, 1978
- A comparison of the bronchodilator activity of Sch 1000 and salbutamolJournal of Allergy and Clinical Immunology, 1977